APA

Ielo L., Deri B., Germanò M. P., Vittorio S., Mirabile S., Gitto R., Rapisarda A., Ronsisvalle S., Floris S., Pazy Y., Fais A., Fishman A. & De Luca L. (20191002). Exploiting the 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors as anti-melanogenic agents: Design, synthesis, structural insights and biological profile. : European journal of medicinal chemistry.

Chicago

Ielo Laura, Deri Batel, Germanò Maria Paola, Vittorio Serena, Mirabile Salvatore, Gitto Rosaria, Rapisarda Antonio, Ronsisvalle Simone, Floris Sonia, Pazy Yael, Fais Antonella, Fishman Ayelet and De Luca Laura. 20191002. Exploiting the 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors as anti-melanogenic agents: Design, synthesis, structural insights and biological profile. : European journal of medicinal chemistry.

Harvard

Ielo L., Deri B., Germanò M. P., Vittorio S., Mirabile S., Gitto R., Rapisarda A., Ronsisvalle S., Floris S., Pazy Y., Fais A., Fishman A. and De Luca L. (20191002). Exploiting the 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors as anti-melanogenic agents: Design, synthesis, structural insights and biological profile. : European journal of medicinal chemistry.

MLA

Ielo Laura, Deri Batel, Germanò Maria Paola, Vittorio Serena, Mirabile Salvatore, Gitto Rosaria, Rapisarda Antonio, Ronsisvalle Simone, Floris Sonia, Pazy Yael, Fais Antonella, Fishman Ayelet and De Luca Laura. Exploiting the 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors as anti-melanogenic agents: Design, synthesis, structural insights and biological profile. : European journal of medicinal chemistry. 20191002.